US regulators laid out new guidelines for approving custom-made treatments for individual patients, a move that could bring ...

From infancy and usually for life, some families suffer from broken hair due to a congenital form of hair loss called monilethrix. Researchers at have now identified causative mutations in another ...

SCN2A related-disorders, although rare in the general population, are one of the more common single-gene neurodevelopmental conditions characterized by infantile seizures, autism spectrum disorder and ...

Researchers developed a new gene-editing strategy that dramatically boosts the effectiveness of gene therapies in the liver, a breakthrough that could lead to new treatments for about 700 genetic ...

Watch: ‘Survivor’ contestant jumps into action to help co-competitor with autism ...

BEIJING — In a mostly empty coworking office on the outskirts of China's capital, a scientist whose name is etched in history is trying to stage a comeback. He Jiankui announced nearly five years ago ...

Gavin Bowen-Metcalf does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations ...

CRISPR, the gene-editing technology that has revolutionized biological research, is finally available as a medical treatment with regulatory approval. On December 8 the U.S. Food and Drug ...

(from left) Dr. Buket Basmanav, Nicole Cesarato, Xing Xiong, Prof. Regina Betz and Yasmina Gossmann find causative mutations in the keratin 31 gene for the dominantly-inherited form of monilethrix.